Press Releases

Featured Press Releases

BIO Applauds Introduction of Bipartisan…

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

Learn more

BIO International Convention Celebrates Another…

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

Learn more

BIO Recognizes Industry Leaders for…

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

Learn more

SCOTUS should preserve FDA's "mandated authority" and "scientific and medical expertise" in new case

December 13, 2023

Today, the Supreme Court announced it will soon weigh in on a case that challenges how the Food and Drug Administration (FDA) regulates mifepristone, a drug it approved almost 25 years ago. BIO interim president and CEO, Rachel King, made the…

New Survey Finds Majority of Americans Support Incentivizing Biotech to Address Climate Change

December 8, 2023

Most Americans Recognize that Biotech Is ‘Climate Tech’ A new poll from the Biotechnology Innovation Organization (BIO) shows that majorities of Americans agree that biotech plays an important role in addressing climate change and federal…

New BIO Poll Reveals Americans Strongly Support the Orphan Cures Act

December 7, 2023

Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development. The…

Using March-In as a Price Control Mechanism Is a “Dangerous Precedent To Set”

December 7, 2023

The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO's Chief Advocacy Officer…

Industry Leader and Globally Recognized Patient Advocate John F. Crowley Appointed to Lead BIO as President & CEO

December 5, 2023

The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…

BIO Commends USDA-APHIS Regulatory Announcements

November 21, 2023

The Department of Agriculture’s Animal and Plant Health Inspection Service recently announced exemptions from regulations under the Plant Protection Act for several categories of plants with genetic modification that could be achieved through…

BIO Statement on WHO Pandemic Accord Negotiating Draft

October 24, 2023

After the release of the World Health Organization Pandemic Accord negotiating draft, BIO's Senior Vice President of Infectious Disease & Emerging Science Policy, Phyllis Arthur, made the following remarks: “The Biotechnology Innovation…

New USITC report shows "no credible evidence" supporting a TRIPs waiver expansion

October 17, 2023

The United States International Trade Commission (USITC) today released its “COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities” report. The report aims to analyze various issues and information gaps concerning…

Indiana Governor Eric Holcomb named BIO’s Governor of the Year

October 16, 2023

Today, the Biotechnology Innovation Organization (BIO) awarded Indiana Governor Eric Holcomb with its 2023 Governor of the Year Award. Throughout his tenure, Governor Holcomb has worked to support the promise of future bioscientific innovation and…

New BIO Working Groups Give Growing Ag & Environment Biotech Sector a Public Policy Voice

September 27, 2023

Updated regulatory working groups announced today by the Biotechnology Innovation Organization (BIO) reflect the rapidly increasing diversity and impact of BIO’s Agriculture & Environment membership and ensure that all member companies’…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.